← For Healthcare Practices

HIPAA Compliance · Dermatology Specialty

HIPAA Compliance for
Dermatology Practices.

Written, OCR-defensible Risk Analysis for general, cosmetic, and aesthetic dermatology practices. Including tracking-pixel exposure review, clinical photography protocols, and BAA inventory across the medical and aesthetic systems most practices run side-by-side. CIPP/US certified. Three weeks.

First Step

Free Consultation

Timeline

3 weeks

Format

Flat fee, written

Why Dermatology Has a Distinct HIPAA Risk Profile

Imaging, Marketing, and Trackers.
Three Places Most Risk Analyses Miss.

Dermatology sits at the intersection of medical care, aesthetic services, and visual marketing. Each part introduces HIPAA risk patterns that a generic Risk Analysis tends to leave incomplete.

01

Tracking Pixels Have Cost Healthcare Entities $35M+ in 2024

The HHS OCR Bulletin on Use of Online Tracking Technologies, originally issued December 1, 2022 and updated in March 2024, treats Meta Pixel, Google Analytics, and similar trackers placed on authenticated PHI pages without a BAA as impermissible disclosure. The first 11 months of 2024 saw more than $35 million in tracking-pixel settlements across healthcare entities. Dermatology practices running condition-specific landing pages (acne, psoriasis, skin cancer) face elevated exposure.

02

Clinical Photography Generates High-Volume Image PHI

Dermatology relies on photographic documentation for diagnosis, treatment planning, and outcomes. Each photo is PHI when it identifies the patient. Storage, transmission, retention, and access controls all require Risk Analysis attention. Practice management vendors who store images must have BAAs covering image data specifically. Before-and-after photo galleries used in marketing require separate written authorization under 45 CFR 164.508.

03

Aesthetic and Medical Systems Often Share Infrastructure

Many practices run general dermatology and aesthetic services through the same scheduling system, the same email infrastructure, and the same patient relationship management tools. This creates BAA scope confusion. An injectable booking tool may not be HIPAA-regulated when used for purely aesthetic services, but when the same tool also schedules a Mohs procedure, the entire system is in scope. The Risk Analysis has to draw the boundary carefully.

04

The Patient Volume Is High and the Encounters Are Brief

A typical dermatology practice sees many short encounters per day, often with quick handoffs between front desk, medical assistant, and provider. The schedule is visible in the front of the practice, the workflow is fast, and patient names and conditions can become audible across the operatory. Each of these is an administrative-safeguard concern under 45 CFR 164.308(a)(3) that should be addressed specifically in the Risk Analysis.

Your Dermatology Practice Has
More HIPAA Surface Than Most.

Book a free 30-minute consultation. No pitch, no pressure. We will tell you whether a Risk Analysis is the right next step or whether the $750 Privacy Exposure Review is a better starting point.

Book a Free Consultation